Clinical Trial Update: Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sintilimab in combination with chidamide for newly diagnosed extranodal NK/T-cell lymphoma (ENKTCL) focusing on safety and e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Sintilimab (sintilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Safety and Efficacy | Phase 2 | Status: UNKNOWN